Key result
Traditional heart failure medications, including beta-blockers, renin-angiotensin system blockers, and statins, are reviewed for their effects on preventing sudden cardiac death.
Why the study?
Do traditional heart failure medications prevent sudden cardiac death in post-MI and systolic heart failure patients?
Population
Post myocardial infarction (MI) patients and patients with systolic heart failure
Design
Review
Authors
Loading...
Summarizes evidence for SCD prevention with traditional HF therapies; leaves open questions on additive effects with newer agents.
Do traditional heart failure medications prevent sudden cardiac death in post-MI and systolic heart failure patients?
This review summarizes the evidence for traditional heart failure medications, including beta-blockers, renin-angiotensin system blockers, and statins, in preventing sudden cardiac death among post-MI and systolic heart failure patients.
M. Obadah Al Chekakie (2013) conducted a review in Sudden cardiac death. Traditional heart failure medications (β-blockers, Renin Angiotensin system blockers, Statins) was evaluated. Traditional heart failure medications, including beta-blockers, renin-angiotensin system blockers, and statins, are reviewed for their effects on preventing sudden cardiac death.